CL2016003220A1 - Formulaciones intravaginales que comprenden gnrh. - Google Patents

Formulaciones intravaginales que comprenden gnrh.

Info

Publication number
CL2016003220A1
CL2016003220A1 CL2016003220A CL2016003220A CL2016003220A1 CL 2016003220 A1 CL2016003220 A1 CL 2016003220A1 CL 2016003220 A CL2016003220 A CL 2016003220A CL 2016003220 A CL2016003220 A CL 2016003220A CL 2016003220 A1 CL2016003220 A1 CL 2016003220A1
Authority
CL
Chile
Prior art keywords
gnrh
intravaginal
formulations
intravaginal formulations
Prior art date
Application number
CL2016003220A
Other languages
English (en)
Inventor
Kenneth L Feenstra
Laibin Luo
Susan C Sucheta
Nicholas A Wicks
Karen P Kolbasa
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of CL2016003220A1 publication Critical patent/CL2016003220A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CL2016003220A 2014-06-16 2016-12-15 Formulaciones intravaginales que comprenden gnrh. CL2016003220A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462012523P 2014-06-16 2014-06-16

Publications (1)

Publication Number Publication Date
CL2016003220A1 true CL2016003220A1 (es) 2017-06-02

Family

ID=53773489

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016003220A CL2016003220A1 (es) 2014-06-16 2016-12-15 Formulaciones intravaginales que comprenden gnrh.

Country Status (14)

Country Link
US (1) US20170143786A1 (es)
EP (1) EP3154519A1 (es)
JP (1) JP2017519769A (es)
CN (1) CN106456705A (es)
AR (1) AR100846A1 (es)
AU (1) AU2015277613A1 (es)
BR (1) BR112016028875A2 (es)
CA (1) CA2951532A1 (es)
CL (1) CL2016003220A1 (es)
IL (1) IL249121A0 (es)
MX (1) MX2016016768A (es)
RU (1) RU2016146994A (es)
UY (1) UY36168A (es)
WO (1) WO2015195333A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11376220B2 (en) * 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211769A (en) * 1977-08-24 1980-07-08 Takeda Chemical Industries, Ltd. Preparations for vaginal administration
ATE508733T1 (de) * 1996-03-04 2011-05-15 Penn State Res Found Materialien und verfahren zur steigerung der zellulären internalisierung
CN101692985A (zh) * 2009-09-29 2010-04-14 浙江大学 一种诱导奶牛定时排卵进行人工授精的方法
CN101779988A (zh) * 2010-02-03 2010-07-21 李树静 一种青年牛高强度重复超数排卵的方法

Also Published As

Publication number Publication date
RU2016146994A3 (es) 2018-07-16
BR112016028875A2 (pt) 2017-08-22
CN106456705A (zh) 2017-02-22
MX2016016768A (es) 2017-04-04
US20170143786A1 (en) 2017-05-25
UY36168A (es) 2016-01-29
IL249121A0 (en) 2017-01-31
AR100846A1 (es) 2016-11-02
EP3154519A1 (en) 2017-04-19
JP2017519769A (ja) 2017-07-20
WO2015195333A1 (en) 2015-12-23
RU2016146994A (ru) 2018-07-16
AU2015277613A1 (en) 2016-12-08
CA2951532A1 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
IL268697A (en) Formulations
DK3688162T3 (da) Formuleringer
DK3627029T3 (da) Manipulationssikret låg
IL246978A0 (en) Novel pharmaceutical formulations
DK3200886T3 (da) Spilsystem
DK3094351T3 (da) Immunmodulatoriske midler
BR112016023628A2 (pt) composições farmacêuticas.
EP3364945C0 (en) SOLID FORMULATION
FR3023988B3 (fr) .
EP3612761C0 (en) COUPLING ELEMENT
EP3478285A4 (en) DEPOSIT FORMULATIONS
ES1150114Y (es) Abarcón.
HUE063178T2 (hu) Kopanlizib formulációi
IL272167A (en) Hemopexin formulations
DK3171961T3 (da) Monolitisk honeycombstruktur
DK3148513T3 (da) Ceritinib-formulering
DK3193856T3 (da) Formulering
EP3565600A4 (en) DEPOSIT PREPARATIONS
TR201503831A2 (tr) Antimipertansif kombinasyon formülasyonları
CL2016003220A1 (es) Formulaciones intravaginales que comprenden gnrh.
FR3023057B1 (fr) Declencheur magnetothermique.
IT201600131035A1 (it) Dispositivo pulisci-vetro.
ITUA20164243A1 (it) Dispositivo tiracavo.
HK1236438A1 (en) Intravaginal formulations comprising gnrh
EP3416646A4 (en) Pemetrexed FORMULATIONS